# BMT Autologous MSCs for GvHD

> **NCT02359929** · PHASE1 · COMPLETED · sponsor: **Emory University** · enrollment: 11 (actual)

## Conditions studied

- Graft Versus Host Disease
- Acute Graft Versus Host Disease
- Chronic Graft Versus Host Disease

## Interventions

- **BIOLOGICAL:** Autologous mesenchymal stromal cells (MSCs)

## Key facts

- **NCT ID:** NCT02359929
- **Lead sponsor:** Emory University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-01
- **Primary completion:** 2020-06-15
- **Final completion:** 2021-01-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2023-01-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02359929

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02359929, "BMT Autologous MSCs for GvHD". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02359929. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*